1. Home
  2. MTA vs CTKB Comparison

MTA vs CTKB Comparison

Compare MTA & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalla Royalty & Streaming Ltd.

MTA

Metalla Royalty & Streaming Ltd.

HOLD

Current Price

$7.41

Market Cap

636.3M

Sector

N/A

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.65

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTA
CTKB
Founded
1983
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.3M
541.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MTA
CTKB
Price
$7.41
$4.65
Analyst Decision
Hold
Hold
Analyst Count
1
4
Target Price
$9.00
$5.63
AVG Volume (30 Days)
443.2K
2.1M
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$81.63
$5.42
Revenue Next Year
$62.44
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.67
52 Week Low
$3.77
$3.09
52 Week High
$9.25
$6.18

Technical Indicators

Market Signals
Indicator
MTA
CTKB
Relative Strength Index (RSI) 52.87 59.27
Support Level $6.35 $4.56
Resistance Level $7.92 $4.78
Average True Range (ATR) 0.37 0.21
MACD -0.00 0.02
Stochastic Oscillator 62.09 76.84

Price Performance

Historical Comparison
MTA
CTKB

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company that engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests. Geographically, the company generates revenue from Australia, Brazil, Mexico, and the USA, with the majority generated from Brazil.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: